ACHR: 13% Slide Extends Selloff as Certification Overhang Persists

What happened

Archer Aviation fell 13.1% over the past month, deepening a downtrend that has erased more than half the stock's value since mid-2025. The Zacks article attributes the weakness to broader market skepticism despite genuine regulatory progress—Archer closed Phase 3 of FAA type certification, secured eIPP program selections in three states, and advanced a UAE restricted type certificate pathway. However, the DeepValue analysis underscores that the market is now pricing Archer as a certification countdown, not a TAM story. The critical missing proof point remains public disclosure of full piloted transition and Phase 4 evidence, which Archer has not yet provided even as rival Joby has flown its first FAA-conforming aircraft. With Q1 2026 operating cash burn of $149M and a net loss of $218M, the $1.78B cash cushion provides time but the stock will remain range-bound until the company converts milestone language into aircraft-level proof.

Implication

Archer's balance sheet supports a 12–18 month runway, but the stock will stay dead money if the company fails to demonstrate full piloted transition or FAA-conforming testing by year-end. The $4.25 attractive entry suggested by DeepValue is only actionable if certification evidence emerges; otherwise, dilution risk and competitive erosion (vs. Joby) keep downside open. Focus on Q3 2026 updates for the missing technical proof that could unlock a re-rating toward $6.50–$7.50.

Thesis delta

The recent 13% decline reflects the market's impatience with Archer's missing technical proof, making the stock more dependent than ever on a single milestone—full piloted transition. While the base scenario (45% probability) still projects a narrow commercial rollout and $5.50 value, the failure to deliver that evidence by Q3 2026 shifts probability toward the bear case ($3.50) as sentiment erodes and cash burn continues. The investment thesis now hinges on whether Archer can provide FAA-conforming transition evidence within the next 6 months; without it, the cash cushion becomes a countdown to dilution rather than a bridge to revenue.